Jan 11, 2012

Experimental neuroblastoma drug shows promise in the lab

Laboratory studies in the US have confirmed the promise of an experimental drug against a particularly aggressive form of neuroblastoma, the most common non-blood cancer in children.

AYA Patients With Cancer, ‘In Between’ Kids and Adults, Face Unique Concerns

New Research Shows Inherited Genetic Variants Increase Risk of Certain Pediatric Cancers

Menin inhibitor clinical trial puts pediatric leukemia patient in remission

Infantile Fibrosarcoma and Other Solid Tumors Respond Well to Precision Medicine

Why copper could be key to treating a rare childhood cancer

Innovative surgery preserves limb growth for childhood bone cancer patients

CAR-T Cell Therapy Shows EFS Benefit in Pediatric Leukemia Subset

Global clinical trial shows improved survival rates for common childhood leukemia

More than half of children with cancer die in the hospital

A new CHOP research program is exploring ways to reduce long-term effects of cancer treatment

Recent Posts

Experimental neuroblastoma drug shows promise in the lab

Archive

Search By Tags